Figure 1From: Fuzheng Kang’ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trialStudy flowchart. FZKA, Fuzheng Kang’ai decoction.Back to article page